ReviewCancers2021

PD-1/PD-L1 Checkpoints and Resveratrol: A Controversial New Way for a Therapeutic Strategy.

Dominique Delmas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.